This inventor holds 2 USPTO granted patents. Top assignee: Akzo N.v.. Active years: 1993-1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-1994
Title: The Innovative Contributions of Franciscus M Kaspersen
Introduction
Franciscus M Kaspersen is a notable inventor based in Heesch, Netherlands. He has made significant contributions to the field of immune therapy, particularly in the development of novel immunoconjugates. With a total of 2 patents, Kaspersen's work is paving the way for advancements in cancer treatment.
Latest Patents
Kaspersen's latest patents include "Acid-labile linker molecules" and "Radioimmunotherapy using α-particles emission." The first invention focuses on the use of acid-cleavable linker molecules to release substances bound to targeting moieties, specifically in the context of immunotherapy for cancer. The second patent relates to the use of Actinium or its daughters in radioimmunotherapy, providing immunoconjugates that are particularly useful for treating micrometastases and localized tumors.
Career Highlights
Kaspersen is associated with Akzo N.V., a company known for its innovative solutions in various sectors. His work at Akzo N.V. has allowed him to explore and develop groundbreaking technologies that enhance cancer treatment methodologies.
Collaborations
Kaspersen has collaborated with notable colleagues such as Petrus J Boon and Ebo S Bos. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Franciscus M Kaspersen's innovative work in the field of immune therapy exemplifies the impact of dedicated inventors on modern medicine. His patents are a testament to his commitment to improving cancer treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile